Oncogenesis, Published online: 14 September 2026; doi:10.1038/s41389-026-00655-9

Acrolein- thioredoxin 1- p38 signaling drives neutrophil-mediated immunosuppression and glioblastoma progression

Oncogenesis, Published online: 31 August 2026; doi:10.1038/s41389-026-00654-w

Compartmentalisation of death receptor signalling in cancer

Oncogenesis, Published online: 31 August 2026; doi:10.1038/s41389-026-00651-z

NKCC1 as a regulator of stemness and redox balance in colorectal cancer

Oncogenesis, Published online: 29 August 2026; doi:10.1038/s41389-026-00653-x

Stanniocalcin 1 contributes to glioma stem cells phenotypic plasticity through NOTCH1/STAT3/GFPT2 axis

Oncogenesis, Published online: 21 August 2026; doi:10.1038/s41389-026-00650-0

CD44v5 promotes triple-negative breast cancer cisplatin resistance by enhancing IL-4/IL-4Rα/STAT3 pathway and stabilizing membranous SLC7A11

Oncogenesis, Published online: 21 August 2026; doi:10.1038/s41389-026-00643-z

A novel combinatorial treatment for Neurofibromatosis type 1 tumours revealed through cross-species genetic analysis

Oncogenesis, Published online: 20 August 2026; doi:10.1038/s41389-026-00652-y

Dual downregulation of HRK and BAD promotes BCL-xL-mediated docetaxel resistance in prostate cancer

Oncogenesis, Published online: 20 August 2026; doi:10.1038/s41389-026-00648-8

The role of m⁶A reader YTHDF2 in lymphangiogenesis via RNF43/WNT5B in oral squamous cell carcinoma

Oncogenesis, Published online: 11 August 2026; doi:10.1038/s41389-026-00649-7

Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy

Oncogenesis, Published online: 21 May 2026; doi:10.1038/s41389-026-00628-y

Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways

Oncogenesis, Published online: 20 May 2026; doi:10.1038/s41389-026-00625-1

Metabolic vulnerabilities in pleural mesothelioma

Oncogenesis, Published online: 16 May 2026; doi:10.1038/s41389-026-00623-3

Multi-omics analysis reveals LARP1 as a key integrator of translation and metabolism in AML

Oncogenesis, Published online: 15 May 2026; doi:10.1038/s41389-026-00627-z

SHP1 expression in tumor-associated dendritic cells drives immunoevasion via impairing CD8⁺ memory T cell responses

Oncogenesis, Published online: 15 May 2026; doi:10.1038/s41389-026-00629-x

Metabolic vulnerabilities and therapeutic opportunities in diffuse large B-cell lymphoma

Oncogenesis, Published online: 12 May 2026; doi:10.1038/s41389-026-00620-6

Imbalances of mitochondrial dynamics in solid tumors

Oncogenesis, Published online: 08 May 2026; doi:10.1038/s41389-026-00621-5

Ubiquitin-specific protease 11 suppresses cuproptosis in colorectal cancer by regulating the ubiquitination and stability of ISCU

Oncogenesis, Published online: 07 May 2026; doi:10.1038/s41389-026-00622-4

Metabolic modulation of immune cell function: mechanisms and therapeutic implications in cancer immunotherapy

Oncogenesis, Published online: 19 April 2026; doi:10.1038/s41389-026-00619-z

PRMT6-mediated EZH2 arginine methylation is critical for breast cancer development

Oncogenesis, Published online: 17 April 2026; doi:10.1038/s41389-026-00615-3

Metastasis suppressing properties of the cell-surface anchored serine protease prostasin: new functional and mechanistic insights from breast cancer

Oncogenesis, Published online: 13 April 2026; doi:10.1038/s41389-026-00614-4

SREBP2 regulates CCDC25 expression and promotes tumor metastasis in Triple-Negative Breast Cancer